Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
about
Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors: A Systematic Review and Meta-AnalysisInflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsR-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and MetastasisMultimodal hazard rate for relapse in breast cancer: quality of data and calibration of computer simulation.NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysisExploiting the critical perioperative period to improve long-term cancer outcomesIs the Neutrophil-to-Lymphocyte Ratio more correlated than C-reactive protein with postoperative complications after major abdominal surgery?Prognostic role of NLR in urinary cancers: a meta-analysisPrognostic role of the neutrophil-lymphocyte ratio in renal cell carcinoma: a meta-analysisCombination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patientsPerioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study.Prognostic value of neutrophil-to-lymphocyte ratio in breast cancer.Cancer Recurrence and Regional Anesthesia: The Theories, the Data, and the Future in Outcomes.Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients.The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.Biological inflammatory markers mediate the effect of preoperative pain-related behaviours on postoperative analgesics requirementsRepurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentThe Pretreatment Neutrophil/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer.Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis.Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentPrognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Nonmetastatic Renal Cell Carcinoma: A Large, Multicenter Cohort Analysis.Perspectives in anaesthesia for cancer surgery.Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.Evaluating the Impact of Total Intravenous Anesthesia on the Clinical Outcomes and Perioperative NLR and PLR Profiles of Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.The prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer: Deleterious or advantageous?Preoperative biliary drainage-related inflammation is associated with shorter survival in biliary tract cancer patients.Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agentLong-term Consequences of the Acute Neural-Inflammatory Stress Response in the Cancer Surgical Patient: New Findings and PerspectivesPrognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes.The perioperative immune/inflammatory insult in cancer surgery: Time for intervention?Prognostic significance of neutrophil-lymphocyteratio/platelet-lymphocyteratioin lung cancers: a meta-analysis.Prognostic significance of the ratio of absolute neutrophil to lymphocyte counts for breast cancer patients with ER/PR-positivity and HER2-negativity in neoadjuvant setting.Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.Prognostic role of pretreatment neutrophil to lymphocyte ratio in breast cancer patients: A meta-analysis.Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery.The Effects of Anesthetics on Recurrence and Metastasis of Cancer, and Clinical Implications.The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.Effects of anaesthesia on proliferation, invasion and apoptosis of LoVo colon cancer cells in vitro.
P2860
Q26786160-2E822388-0FBB-4BA4-9BBD-5FC47FA80DC8Q27009534-A08A7A05-0236-4DF5-B66A-D3875D575B99Q28265491-36F628B0-58E9-4B64-8E96-CF05040D0283Q30872612-8BC61383-0395-4C51-BEB7-A1288F0DB19FQ33687606-49B24AA6-25F5-4461-8E7C-3B47486AC347Q33871661-59B05432-9BDB-4A26-AB5A-25558659C365Q35007368-B088481A-EA87-45F9-B151-3EFA833E81E9Q35124106-C44318AB-726F-4CF0-9DD5-03897E390C0FQ35332425-A0BB2B17-5593-4628-B8AB-E21434A3A79AQ35663441-46949D1A-B8C1-4865-8117-60D5BCF7FB7BQ35755373-DAE48684-CD76-4979-A5F6-693D7C5AF923Q35790197-BE02973F-A7FC-4503-B59D-674D0A89D2A5Q35800595-B862BD2B-869D-4F46-8D51-AC90D445061CQ35817001-122C43C5-009D-4300-B6BB-6F2B14A295A5Q35845330-C53BBBF2-880E-45C2-AB1A-7CBE62806A1EQ35884531-218D8450-338D-4059-9BDF-EE92749246B1Q36279606-FA44BD63-F1F2-4497-8EEB-D9575DB600BEQ36376791-0602A6E7-A4DD-46BE-A0A5-7316CC5A78C1Q36483712-F795359B-8B9C-4AC5-BB00-7ABAE86A7A54Q36749454-21CF238C-49BB-47AD-B89B-4F652E771D8EQ37296336-BE7840E5-0524-46BD-AEAE-13823A58A5CFQ37404693-2EB8FA4D-BDF6-462B-BC81-2A2BAA10BA75Q37424266-C8DF5D38-23DE-4AF7-9507-39DAAF1934A8Q38146832-675657E6-54DB-4B42-9321-194CCFB787E2Q38769899-FCFD6E74-04C8-41DC-97BE-6945B2764A24Q38774380-CDD8DC3A-41B2-4F80-B692-F7CF98034CEAQ39400399-B44D9258-7210-4C11-BC49-7E6835499CE3Q39984675-72493C9F-49B0-46D3-90B9-6A9A1F2F1798Q41327770-3CDD0453-AD36-423A-99FE-9E7080F5CD24Q41585931-27D45151-EDC7-4CE7-A828-1A83A9E291A8Q41719270-585A65CE-96BA-47E9-A84C-2356BB044A1DQ41788262-50B506F9-04F8-4C56-AC6A-23977E901B6FQ42314596-37D05905-7DC3-4AC4-A955-0BC0A60E7A97Q44173035-C778F4F4-C149-47F0-97A6-29001A37BE31Q44586148-D3A22B96-8E6D-4147-AB4B-D73F116A5D81Q45284997-9D86F435-C645-4CF6-8DB0-5C5232DE668AQ45445334-860821CC-C7C3-4722-A93A-2DEDC8648934Q47106600-854B2A7B-761B-4BF4-BB34-C81DA0EFBC1FQ47338550-51084FC7-6C6E-47C0-B100-EF279AC5F32EQ47615831-049DDB30-8FE0-4FBA-8D83-69C84037305B
P2860
Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Neutrophil:lymphocyte ratio an ...... ng, and kidney cancer surgery.
@en
Neutrophil:lymphocyte ratio an ...... ng, and kidney cancer surgery.
@nl
type
label
Neutrophil:lymphocyte ratio an ...... ng, and kidney cancer surgery.
@en
Neutrophil:lymphocyte ratio an ...... ng, and kidney cancer surgery.
@nl
prefLabel
Neutrophil:lymphocyte ratio an ...... ng, and kidney cancer surgery.
@en
Neutrophil:lymphocyte ratio an ...... ng, and kidney cancer surgery.
@nl
P2093
P2860
P1476
Neutrophil:lymphocyte ratio an ...... ng, and kidney cancer surgery.
@en
P2093
Alain J Poncelet
Annabelle Stainier
Bertrand Tombal
Catherine Legrand
Jean-Luc Canon
Jean-Pascal Machiels
Marc De Kock
Martine Berliere
Pierre G Coulie
Yann Kremer
P2860
P2888
P304
P356
10.1245/S10434-013-3136-X
P478
20 Suppl 3
P577
2013-07-25T00:00:00Z
P6179
1045568738